Publications
2025
-
Yichen Li#, Wenxia Wang#, Ruixin Zhu*, Xinyue Zhu, Mingwei Sun, Yanlan Huang, Wanning Chen, Sheng Gao, Na Jiao, Xutao Lin, Jia Ke, Tao Xu, Linlin Hou*, Ping Lan*, Lixin Zhu*. (2025). STAT1 mediates the pro-inflammatory role of GBP5 in colitis, Communications Biology.
-
Mengping Shen#, Sheng Gao#, Ruixin Zhu*, Wei Wang, Wenxing Gao, Liwen Tao, Wanning Chen, Xinyue Zhu, Yuwei Yang, Tingjun Xu, Tingting Zhao, Na Jiao*>, Min Zhi*, Lixin Zhu*. (2025) Multimodal Metagenomic Analysis Reveals Microbial InDels as Superior Biomarkers for Pediatric Crohn’s Disease, Journal of Crohn’s and Colitis. 2025, 19(4):jjaf039
-
Suqi Cao#, Lei Liu#, Liu Yang, Haomin Li, Ruixin Zhu, Gang Yu, Na Jiao*, Dingfeng Wu*. (2025). Assessing severe pneumonia risk in children via clinical prognostic model based on laboratory markers, International Immunopharmacology
-
Yuwei Yang#, Wenxing Gao#, Ruixin Zhu*, Liwen Tao, Wanning Chen, Xinyue Zhu, Mengping Shen, Tingjun Xu, Tingting Zhao, Xiaobai Zhang, Lixin Zhu*, Na Jiao*. Systematic identificationof secondary bile acid production genes in global microbiome, mSystems, 2025: e00817-24.
2024
- Wenxing Gao#, Weili Lin#, Qiang Li#, Wanning Chen, Wenjing Yin, Xinyue Zhu, Sheng Gao, Lei Liu, Wenjie Li, Dingfeng Wu, Guoqing Zhang*, Ruixin Zhu*, Na Jiao*. Identification and validation of microbial biomarkers from cross-cohort datasets using xMarkerFinder, Nature Protocols, 2024, https://doi.org/10.1038/s41596-024-00999-9.
- Na Jiao*, Lixin Zhu*, Ruixin Zhu*. The search for authentic microbiome–disease relationships. Nature Medicine. 2024, https://doi.org/10.1038/s41591-024-02920-z
- Xinyue Zhu#, Pingping Xu#, Ruixin Zhu*, Wenxing Gao, Wenjing Yin, Ping Lan, Lixin Zhu*, Na Jiao*, Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis, Communications Biology, 2024, 7:24, 10.1038/s42003-023-05714-0
- Xiaoyi Li#, Dingfeng Wu#, Qiuyu Li, Jinglan Gu, Wenxing Gao, Xinyue Zhu, Wenjing Yin, Ruixin Zhu*, Lixin Zhu*, Na Jiao*, Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer, Physiological Genomics. 2024,56 (2), 221-234
2023
-
Wenxing Gao#, Xiang Gaosup>#</sup>, Lixin Zhu*, Sheng Gao, Ruicong Sun, Zhongsheng Feng, Dingfeng Wu, Zhanju Liu*, Ruixin Zhu*, Na Jiao*, Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. Gut Microbes, 2023; https://doi.org/10.1080/19490976.2023.2245562.
-
Sheng Gao#, Xiang Gao#, Ruixin Zhu*, Dingfeng Wu, Zhongsheng Feng, Na Jiao, Ruicong Sun, Wenxing Gao, Qing He*, Zhanju Liu*, Lixin Zhu*. Microbial genes outperform species and SNVs as diagnostic markers for Crohn’s disease on multicohort fecal metagenomes empowered by artificial intelligence. Gut microbes, 2023, 15(1): 2221428.
-
Tingjun Xu#, Wenxing Gao#, Lixin Zhu*, Wanning Chen, Chaoqun Niu, Wenjing Yin, Liangxiao Ma, Xinyue Zhu, Yunchao Ling, Sheng Gao, Lei Liu, Na Jiao, Weiming Chen, Guoqing Zhang*, Ruixin Zhu*, and Dingfeng Wu*. NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease. J. Chem. Inf. Model. 2023; https://pubs.acs.org/doi/10.1021/acs.jcim.3c00395
-
Xiang Gao#, Ruicong Sun#, Na Jiao#, Xiao Liang, Gengfeng Li, Han Gao, Xiaohan Wu, Muqing Yang, Chunqiu Chen, Liang Chen, Wei Wu, Zhong Li, Yingzi Cong, Ruixin Zhu*, Tiannan Guo*, Zhanju Liu*, Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn’s disease. Cell Reports Medicine. 2023; 4, 101050.
-
Fengtao Cai#, Chenfen Zhou#, Na Jiao#, Xinling Liang, Zhiming Ye, Wei Chen, Qiongqiong Yang, Hui Peng, Ying Tang, Chaoqun Niu, Guoping Zhao, Zefeng Wang*, Guoqing Zhang*, Xueqing Yu*. Systematic microbiome dysbiosis are associated with IgA nephropathy. Microbiology Spectrum. 2023, e05202-22.
-
Shaobo Zhao#, Kun Zhu#, Xiaoyi Li#, Xiaohui Zhong, Yanyan Zhao, Zhicong Liu, Yi Xiao, Dengming Lai, Na Jiao*, Qiang Shu*. Co-expression and interaction network analysis reveals dysregulated neutrophil and T-cell activation as the core mechanism associated with septic shock[J]. Frontiers in Genetics, 2023, 14.
2022
-
Dingfeng Wu#, Lei Liu#, Na Jiao#, Yida Zhang, Li Yang, Chuan Tian, Ping Lan, Lixin Zhu*, Rohit Loomba*, and Ruixin Zhu*. Targeting Keystone Species Helps Restore the Dysbiosis of Butyrate-Producing Bacteria in Nonalcoholic Fatty Liver Disease. iMeta, 2022; e61. https://doi.org/10.1002/imt2.61
-
Ningning Liu#, Na Jiao#, Jing-Cong Tan#, Ziliang Wang#, Dingfeng Wu, An-Jun Wang, Jie Chen, Liwen Tao, Chenfen Zhou, Wenjie Fang, Io Hong Cheong, Weihua Pan, Wanqing Liao, Zisis Kozlakidis, Christopher Heeschen, Geromy G. Moore, Lixin Zhu*, Xingdong Chen*, Guoqing Zhang*, Ruixin Zhu*, Hui Wang*. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts. Nature Microbiology, 2022; 7(2):238-250.
-
Sheng Gao, Yichen Li, Dingfeng Wu, Na Jiao, Li Yang, Rui Zhao, Zhifeng Xu, Wanning Chen, Xutao Lin, Sijing Cheng, Lixin Zhu*, Ping Lan*, Ruixin Zhu*. IBD subtype-regulators IFNG and GBP5 identified by causal inference drive more intense innate immunity and inflammatory responses in CD than those in UC. Frontiers in Pharmacology, 2022, p.1049.
2021
-
Yuqi Wu#, Na Jiao#, Ruixin Zhu*, Yida Zhang, Dingfeng Wu, An-Jun Wang, Sa Fang, Liwen Tao, Yichen Li, Sijing Cheng, Ping Lan, Chuan Tian*, Ning-Ning Liu*, Lixin Zhu*. Identification of microbial markers across populations in early detection of colorectal cancer. Nature Communications, 2021; 12(1):3063
-
Na Jiao#, Rohit Loomba#*, Zi-Huan Yang, Dingfeng Wu, Sa Fang, Richele Bettencourt, Ping Lan, Ruixin Zhu*, Lixin Zhu*. Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. Physiological Genomics, 2021; 53(8):336-348.
-
Yichen Li#, Jie Li#, Jia Ke#, Na Jiao#, Lixin Zhu#*, Lihan Shen, Lei Chen, Zhiqiang Jiang, Sijing Cheng, Yibo Huang, Yifeng Zou, Ruixin Zhu*, and Guangjun Yan*. Adverse Outcomes Associated with Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study. Frontiers of Medicine, 2021; 8: 604263.
-
Jingrong Weng#, Yichen Li#, Jie Li#, Lihan Shen#, Lixin Zhu#*, Yufan Liang, Xutao Lin, Na Jiao, Sijing Cheng, Yibo Huang, Yifeng Zou*, Guangjun Yan*, Ruixin Zhu*, Ping Lan*. Gastrointestinal sequelae in patients after discharge for COVID-19. The Lancet Gastroenterology & Hepatology. 2021, 6(5): 344-346.
-
Lu Zhao#, Wanning Chen#, Yongsheng Ge, Xin Lv, Ying Wang, Han Yu, Yi Liu, Dingfeng Wu, Na Jiao, Yuanqi Wu, Daqing Lv, Guoqing Zhang, Fuzhong Xue, Xiaohong Xu, Zhongtao Gai*, Ruixin Zhu*, Lei Zhang*, Guoping Zhao. Putative familial transmissible bacteria of various body niches link with home environment and children’s immune health. Microbiology Spectrum. 2021, 9(3): e00872-21.
Before 2021
-
Yichen Li#, Na Jiao#, Lixin Zhu*, Sijing Cheng, Ruixin Zhu*; Ping Lan*.Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study. Critical Care, 2020; 24:314.
-
Sijing Cheng#, Dingfeng Wu#, Jie Li, Yifeng Zou, Yunle Wan, Lihan Shen, Lixin Zhu*, Mang Shi, Linlin Hou, Tao Xu, Na Jiao, Yichen Li, Yibo Huang, Zhipeng Tang, Mingwei Xu, Shusong Jiang, Maokun Li*, Guangjun Yan*, Ping Lan*, and Ruixin Zhu*. Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study. Respiratory Research, 2020; 21(1), 277. DOI: https://doi.org/10.1186/s12931-020-01492-zLu.
-
Dingfeng Wu#, WenxingGao#, Xiaoyi Li#, Chuan Tian, Na Jiao, Sa Fang, Jing Xiao, Zhifeng Xu, Lixin Zhu*, Guoqing Zhang* and Ruixin Zhu*. Dr AFC: Drug Repositioning Through Anti-Fibrosis Characteristic. Briefings in Bioinformatics, 2020; 22(3). DOI: https://doi.org/10.1093/bib/bbaa115.
-
Yunle Wan#, Jie Li#, Lihan Shen#,Yifeng Zou#, Linlin Hou#, Lixin Zhu#,*, Howard S.Faden, Zhipeng Tang, Mang Shi, Na Jiao, Yichen Li, Sijing Cheng, Yibo Huang, Dingfeng Wu, ZhifengXu, Linnuo Pan, Jun Zhu, GuangjunYan*, Ruixin Zhu*, and Ping Lan*. Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. The Lancet Gastroenterology & Hepatology, 2020; 5(6), 534–535. DOI: https://doi.org/10.1016/S2468-1253(20)30118-7.
-
Sheng Gao#, Qian Zhang#, Chuan Tian, Chun Li, Yunzheng Lin, Wenxing Gao, Dingfeng Wu, Na Jiao, Lixin Zhu, Wenzhe Li, Ruixin Zhu*, Wei Wang*, Yong Wang*. The roles of Qishen granules recipes, Qingre Jiedu, Wenyang Yiqi and Huo Xue, in the treatment of heart failure. Journal of Ethnopharmacology, 2020; 249, 112372.
-
Yali Zhang#, Liting Cai#, Junyi Qi, Yunzheng Lin, Yancheng Dai, Na Jiao, Youlan Chen, Lie Zheng, Beibei Wang, Lixin Zhu, Zhipeng Tang*, and Ruixin Zhu. Gut Microbiota Contributes to the Distinction Between Two Traditional Chinese Medicine Syndromes of Ulcerative Colitis. World Journal of Gastroenterology, 2020; 25(25), 3242. (IF=5.374)
- Na Jiao, Susan S Baker*, Adrian Chapa-Rodriguez, Wensheng Liu, Colleen A Nugent, Maria Tsompana, Lucy Mastrandrea, Michael J Buck, Robert D Baker, Robert J Genco, Ruixin Zhu*, Lixin Zhu*. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2018; 67(10):1881-1891
-
Na Jiao, Susan S. Baker, Colleen A. Nugent, Maria Tsompana, Liting Cai, Yong Wang, Michael J. Buck, Robert J. Genco, Robert D. Baker, Ruixin Zhu*, Lixin Zhu*. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. Physiological Genomics. 2018; 50(4):244-254. (APSselect award https://www.physiology.org/toc/apsselect/5/4)
-
Xiaoyi Li#, , Hong Kang, Wensheng Liu, Sarita Singhal, Na Jiao, Yong Wang, Lixin Zhu, Ruixin Zhu*. In silico Design of Novel Proton Pump Inhibitors with Reduced Adverse Effect. Frontiers of Medicine, 2018; 13(2): 277-284. (IF=9.927)
-
Wei Xie#*, Na Jiao#, Cenling Ma, Sa Fang, Tommy J Phelps, Ruixin Zhu*, Chuanlun Zhang. The response of archaeal species to seasonal variables in a subtropical aerated soil: insight into the low abundant methanogens. Applied Microbiology and Biotechnology, 2017;101(16):6505-6515.
- Zhen Sheng#, Yi Sun, Ruixin Zhu, Na Jiao, Kailin Tang, Zhiwei Cao*, Chao Ma*. Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine. PLoS ONE, 2015; 10(11): e0143742.